Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease

Regional loss of immunohistochemically identified neurons in serial sections through the brainstem of 4 patients with idiopathic Parkinson's disease was compared with equivalent sections from 4 age‐matched control subjects. In the Parkinson brains, the catecholamine cell groups of the midbrain, pons, and medulla showed variable neuropathological changes. All dopaminergic nuclei were variably affected, but were most severely affected in the caudal, central substantia nigra. The pontine noradrenergic locus ceruleus showed variable degrees of degeneration. There was also a substantial loss of substance P–containing neurons in the pedunculopontine tegmental nucleus. However, the most severely affected cell group in the pons was the serotonin‐synthesizing neurons in the median raphe. In the medulla, substantial neuronal loss was found in several diverse cell groups including the adrenaline‐synthesizing and neuropeptide Y–containing neurons in the rostral ventrolateral medulla, the serotonin‐synthesizing neurons in the raphe obscurus nucleus, the substance P–containing neurons in the lateral reticular formation, as well as the substance P–containing neurons in the dorsal motor vagal nucleus. Lewy bodies were present in immunohistochemically identified neurons in many of these regions, indicating that they were affected directly by the disease process. These widespread but region‐ and transmitter‐specific changes help account for the diversity of motor, cognitive, and autonomic manifestations of Parkinson''s disease.

[1]  J. Chalmers,et al.  Simultaneous demonstration of phenylethanolamine N-methyltransferase immunofluorescent and catecholamine fluorescent nerve cell bodies in the rat medulla oblongata , 1980, Neuroscience.

[2]  T. Joh,et al.  Evidence for retrograde degeneration of epinephrine neurons in Alzheimer's disease , 1988, Annals of neurology.

[3]  P. Yates,et al.  PATHOLOGICAL BASIS FOR NEUROTRANSMITTER CHANGES IN PARKINSON'S DISEASE , 1983, Neuropathology and applied neurobiology.

[4]  C. Milstein,et al.  Detection of substance P in the central nervous system by a monoclonal antibody. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Eadie THE PATHOLOGY OF CERTAIN MEDULLARY NUCLEI IN PARKINSONISM. , 1963, Brain : a journal of neurology.

[6]  P. Yates,et al.  The topography of cell loss from locus caeruleus in Alzheimer's disease , 1986, Journal of the Neurological Sciences.

[7]  D. German,et al.  Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex , 1987, Neuroscience.

[8]  Y. Agid,et al.  Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.

[9]  T. Hökfelt,et al.  Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata , 1983, Neuroscience Letters.

[10]  T. Joh,et al.  Distribution of monoamine‐synthesizing neurons in the human medulla oblongata , 1988, The Journal of comparative neurology.

[11]  F. E. Bloom,et al.  Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of alzheimer's type , 1983, Neuroscience Letters.

[12]  G. Blessed,et al.  Cell loss in the locus coeruleus in senile dementia of Alzheimer type , 1981, Journal of the Neurological Sciences.

[13]  Larry L. Butcher,et al.  Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain , 1986, Brain Research Bulletin.

[14]  D. Price,et al.  The neuropathology of aminergic nuclei in Alzheimer's disease , 1988, Progress in clinical and biological research.

[15]  C. Duyckaerts,et al.  Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients , 1986, Brain Research.

[16]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[17]  B. Bogerts,et al.  A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. , 1983, Biological psychiatry.

[18]  J. Olszewski,et al.  Cytoarchitecture of the Human Brain Stem , 1955 .

[19]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[20]  D L Price,et al.  Parkinson's disease , 1985, Neurology.

[21]  D L Price,et al.  Aminergic systems in Alzheimer's disease and Parkinson's disease , 1987, Annals of neurology.

[22]  P. Yates,et al.  Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[23]  D. Price,et al.  Reductions in acetylcholine and nicotine binding in several degenerative diseases. , 1988, Archives of neurology.

[24]  T. Joh,et al.  Distribution of substance P‐like immunoreactive neurons in the human medulla oblongata: Co‐localization with monoamine‐synthesizing neurons , 1988, Synapse.

[25]  A M Graybiel,et al.  Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Spencer,et al.  A cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus , 1987, Brain Research.

[27]  A. Hirano,et al.  Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons , 1985, Annals of neurology.

[28]  J. Pearson,et al.  Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase , 1983, Neuroscience.

[29]  D L Price,et al.  The pedunculopontine nucleus in Parkinson's disease , 1989, Annals of neurology.

[30]  G. M. Halliday,et al.  Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease , 1990, Brain Research.

[31]  Wade K. Smith,et al.  The human locus coeruleus: computer reconstruction of cellular distribution , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  Y. Agid,et al.  Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains , 1983, Brain Research.

[33]  A. Graybiel,et al.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.

[34]  M. Fiacco,et al.  Topographical localization of substance P in the human post-mortem brainstem. An immunohistochemical study in the newborn and adult tissue , 1984, Neuroscience.

[35]  H. Fibiger,et al.  Substance P in the ascending cholinergic reticular system , 1983, Nature.

[36]  K. Jellinger,et al.  Overview of morphological changes in Parkinson's disease. , 1987, Advances in neurology.

[37]  T. Joh,et al.  The distribution of neuropeptide Y-like immunoreactive neurons in the human medulla oblongata , 1988, Neuroscience.

[38]  J. Willoughby,et al.  Distribution of tyrosine hydroxylase and neuropeptide Y–like immunoreactive neurons in rabbit medulla oblongata, with attention to colocalization studies, presumptive adrenaline‐synthesizing perikarya, and vagal preganglionic cells , 1986, The Journal of comparative neurology.

[39]  W. Bondareff,et al.  Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia , 1982, Neurology.

[40]  K. Jellinger,et al.  The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[41]  A. Cuello,et al.  Identification of serotonergic neurons in human brain by a monoclonal antibody binding to all three aromatic amino acid hydroxylases , 1987, Brain Research.

[42]  K. Kitahama,et al.  Adrenergic neurons in human brain demonstrated by immunohistochemistry with antibodies to phenylethanolamine-N-methyltransferase (PNMT): Discovery of a new group in the nucleus tractus solitarius , 1985, Neuroscience Letters.